FI75168C - Foerfarande foer framstaellning av natriumcefuroxim eller ett solvat daerav och natriumcefuroximtetrahydrofuransolvat anvaendbart som mellanprodukt vid foerfarandet. - Google Patents
Foerfarande foer framstaellning av natriumcefuroxim eller ett solvat daerav och natriumcefuroximtetrahydrofuransolvat anvaendbart som mellanprodukt vid foerfarandet. Download PDFInfo
- Publication number
- FI75168C FI75168C FI800453A FI800453A FI75168C FI 75168 C FI75168 C FI 75168C FI 800453 A FI800453 A FI 800453A FI 800453 A FI800453 A FI 800453A FI 75168 C FI75168 C FI 75168C
- Authority
- FI
- Finland
- Prior art keywords
- sodium
- cefuroxime
- mixture
- thf
- added
- Prior art date
Links
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 74
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 43
- 239000000203 mixture Substances 0.000 claims description 38
- URDOHUPGIOGTKV-JTBFTWTJSA-M Cefuroxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 URDOHUPGIOGTKV-JTBFTWTJSA-M 0.000 claims description 34
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 33
- 229960000534 cefuroxime sodium Drugs 0.000 claims description 30
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 239000012453 solvate Substances 0.000 claims description 17
- 239000002904 solvent Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 11
- 159000000000 sodium salts Chemical class 0.000 claims description 10
- 229960001668 cefuroxime Drugs 0.000 claims description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 7
- JFPVXVDWJQMJEE-IZRZKJBUSA-N cefuroxime Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 JFPVXVDWJQMJEE-IZRZKJBUSA-N 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- 238000006136 alcoholysis reaction Methods 0.000 claims description 5
- 239000003054 catalyst Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- -1 trichloroacetyl group Chemical group 0.000 claims description 3
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 238000003756 stirring Methods 0.000 description 17
- GRNOZCCBOFGDCL-UHFFFAOYSA-N 2,2,2-trichloroacetyl isocyanate Chemical compound ClC(Cl)(Cl)C(=O)N=C=O GRNOZCCBOFGDCL-UHFFFAOYSA-N 0.000 description 10
- VYPDUQYOLCLEGS-UHFFFAOYSA-M sodium;2-ethylhexanoate Chemical compound [Na+].CCCCC(CC)C([O-])=O VYPDUQYOLCLEGS-UHFFFAOYSA-M 0.000 description 9
- 238000001816 cooling Methods 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 6
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000002178 crystalline material Substances 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000021235 carbamoylation Effects 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 150000002513 isocyanates Chemical class 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- UTQNKKSJPHTPBS-UHFFFAOYSA-N 2,2,2-trichloroethanone Chemical group ClC(Cl)(Cl)[C]=O UTQNKKSJPHTPBS-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004146 Propane-1,2-diol Substances 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Chemical class 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000003849 aromatic solvent Substances 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001030 gas--liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 239000004324 sodium propionate Substances 0.000 description 1
- 229960003212 sodium propionate Drugs 0.000 description 1
- 235000010334 sodium propionate Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7905456 | 1979-02-15 | ||
| GB7905456 | 1979-02-15 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI800453A7 FI800453A7 (fi) | 1980-08-16 |
| FI75168B FI75168B (fi) | 1988-01-29 |
| FI75168C true FI75168C (fi) | 1988-05-09 |
Family
ID=10503234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI800453A FI75168C (fi) | 1979-02-15 | 1980-02-14 | Foerfarande foer framstaellning av natriumcefuroxim eller ett solvat daerav och natriumcefuroximtetrahydrofuransolvat anvaendbart som mellanprodukt vid foerfarandet. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4277601A (en, 2012) |
| JP (1) | JPS55111490A (en, 2012) |
| KR (1) | KR830001905B1 (en, 2012) |
| AT (1) | AT366051B (en, 2012) |
| AU (1) | AU542084B2 (en, 2012) |
| CH (1) | CH646706A5 (en, 2012) |
| DE (1) | DE3005564A1 (en, 2012) |
| DK (1) | DK159449C (en, 2012) |
| ES (1) | ES8101607A1 (en, 2012) |
| FI (1) | FI75168C (en, 2012) |
| FR (1) | FR2482104A1 (en, 2012) |
| GB (1) | GB2043070B (en, 2012) |
| HU (1) | HU182068B (en, 2012) |
| IT (1) | IT1144037B (en, 2012) |
| NL (1) | NL191844C (en, 2012) |
| SE (1) | SE451724B (en, 2012) |
| YU (1) | YU42325B (en, 2012) |
| ZA (1) | ZA80844B (en, 2012) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS588086A (ja) * | 1981-07-07 | 1983-01-18 | Takeda Chem Ind Ltd | セフアロスポリン溶媒和物およびその製造法 |
| GB8320520D0 (en) * | 1983-07-29 | 1983-09-01 | Glaxo Group Ltd | Chemical process |
| AT411996B (de) * | 2000-09-11 | 2004-08-26 | Sandoz Ag | Verfahren zur herstellung von cefuroxim in der form seines n-butylammoniumsalzes |
| WO2004050663A2 (en) * | 2002-12-05 | 2004-06-17 | Orchid Chemicals & Pharmaceuticals Ltd | An improved process for the preparation of cefuroxime sodium |
| ITMI20050871A1 (it) * | 2005-05-13 | 2006-11-14 | Acs Dobfar Spa | Solvato cristallino di cefuroxima acido |
| CN102617604A (zh) * | 2012-02-24 | 2012-08-01 | 天津大学 | 一种耦合反应结晶制备头孢呋辛钠的方法 |
| CN104774211A (zh) * | 2015-04-27 | 2015-07-15 | 四川制药制剂有限公司 | 注射用头孢呋辛钠的制备工艺 |
| WO2017191620A1 (en) * | 2016-05-06 | 2017-11-09 | Sun Pharmaceutical Industries Limited | A crystalline form of a salt of sacubitril and a process of its preparation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3974153A (en) * | 1971-05-14 | 1976-08-10 | Glaxo Laboratories Limited | 7-Hydrocarbonoxy imino-acetamido-3-carbamoyloxy methylceph-3-em-4 carboxylic acids |
| US3905963A (en) * | 1972-01-25 | 1975-09-16 | Lilly Co Eli | Process for preparing primary 3-carbamoyloxymethyl cephalosporins |
| GB1575905A (en) * | 1976-04-28 | 1980-10-01 | Glaxo Lab Ltd | Salt of cefuroxime |
-
1980
- 1980-02-14 JP JP1611880A patent/JPS55111490A/ja active Granted
- 1980-02-14 DE DE19803005564 patent/DE3005564A1/de active Granted
- 1980-02-14 YU YU395/80A patent/YU42325B/xx unknown
- 1980-02-14 FR FR8003269A patent/FR2482104A1/fr active Granted
- 1980-02-14 AT AT0081380A patent/AT366051B/de not_active IP Right Cessation
- 1980-02-14 KR KR1019800000589A patent/KR830001905B1/ko not_active Expired
- 1980-02-14 HU HU80332A patent/HU182068B/hu unknown
- 1980-02-14 CH CH123480A patent/CH646706A5/de not_active IP Right Cessation
- 1980-02-14 IT IT47899/80A patent/IT1144037B/it active
- 1980-02-14 NL NL8000925A patent/NL191844C/xx not_active IP Right Cessation
- 1980-02-14 ZA ZA00800844A patent/ZA80844B/xx unknown
- 1980-02-14 GB GB8005088A patent/GB2043070B/en not_active Expired
- 1980-02-14 ES ES488607A patent/ES8101607A1/es not_active Expired
- 1980-02-14 SE SE8001177A patent/SE451724B/sv not_active IP Right Cessation
- 1980-02-14 US US06/121,531 patent/US4277601A/en not_active Expired - Lifetime
- 1980-02-14 DK DK063280A patent/DK159449C/da not_active IP Right Cessation
- 1980-02-14 AU AU55561/80A patent/AU542084B2/en not_active Ceased
- 1980-02-14 FI FI800453A patent/FI75168C/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR830001905B1 (ko) | 1983-09-19 |
| ES488607A0 (es) | 1980-12-16 |
| FI800453A7 (fi) | 1980-08-16 |
| ZA80844B (en) | 1981-08-26 |
| FI75168B (fi) | 1988-01-29 |
| NL191844C (nl) | 1996-09-03 |
| IT8047899A0 (it) | 1980-02-14 |
| CH646706A5 (de) | 1984-12-14 |
| DE3005564A1 (de) | 1980-09-11 |
| US4277601A (en) | 1981-07-07 |
| YU39580A (en) | 1983-04-30 |
| IT1144037B (it) | 1986-10-29 |
| NL191844B (nl) | 1996-05-01 |
| JPH0240676B2 (en, 2012) | 1990-09-12 |
| SE8001177L (sv) | 1980-08-16 |
| FR2482104A1 (fr) | 1981-11-13 |
| FR2482104B1 (en, 2012) | 1983-11-18 |
| GB2043070A (en) | 1980-10-01 |
| NL8000925A (nl) | 1980-08-19 |
| YU42325B (en) | 1988-08-31 |
| AT366051B (de) | 1982-03-10 |
| ES8101607A1 (es) | 1980-12-16 |
| DK159449B (da) | 1990-10-15 |
| SE451724B (sv) | 1987-10-26 |
| ATA81380A (de) | 1981-07-15 |
| HU182068B (en) | 1983-12-28 |
| JPS55111490A (en) | 1980-08-28 |
| AU5556180A (en) | 1980-08-21 |
| GB2043070B (en) | 1983-03-23 |
| DK159449C (da) | 1991-03-04 |
| DE3005564C2 (en, 2012) | 1989-05-24 |
| DK63280A (da) | 1980-08-16 |
| KR830001952A (ko) | 1983-05-21 |
| AU542084B2 (en) | 1985-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS209878B2 (en) | Method of making the new alcyloxime derivatives of the 7-/2-(2-amino-4-thiazolyl)acetamido/cephalosporan acid | |
| US4775750A (en) | Process for preparing sodium cefuroxime | |
| FI76808B (fi) | Foerfarande foer framstaellning av cefuroxim-1-acetoxietylester. | |
| FI75168C (fi) | Foerfarande foer framstaellning av natriumcefuroxim eller ett solvat daerav och natriumcefuroximtetrahydrofuransolvat anvaendbart som mellanprodukt vid foerfarandet. | |
| FI101965B (fi) | Klavulaanihapon 2-amino-2,4,4-trimetyylipentaanisuolan käyttö klavulaa nihapon alkali- tai maa-alkalimetallisuolojen valmistuksessa | |
| SU541438A3 (ru) | Способ получени ацилуреидоцефалоспоринов или их солей или эфиров | |
| HK110295A (en) | Process for preparing cephalosporin intermediates | |
| US4260607A (en) | Cephalosporin esters | |
| KR100342944B1 (ko) | 고순도 세프포독심 프록세틸의 제조방법 | |
| US4935508A (en) | Process for cephem prodrug esters | |
| US4064241A (en) | 7[(Carboxyoxiran-3-carboxamido)phenylacetamido]cephalosporin derivatives | |
| US4071531A (en) | Oxathiino- and dithiino-aminoacetic acids | |
| KR20020033624A (ko) | β-락탐 유도체의 제조방법 | |
| EP0068403B1 (en) | Cephalosporin compound | |
| KR100423890B1 (ko) | 세팔로스포린 유도체의 새로운 제조방법 | |
| SU608477A3 (ru) | Способ получени производных 3-карбамоилоксиметилцефалоспорина | |
| SU543353A3 (ru) | Способ получени производных 7-монохлорацетамидо-3-дезацетоксицефалоспорановой кислоты | |
| US4137312A (en) | Epoxy substituted cephalosporin derivatives | |
| DK164225B (da) | Cephalosporinforbindelser til anvendelse som ernaeringsmaessige tilskud i dyrefoder | |
| US4216215A (en) | 7[(Furanyl-2-acetamido)-2-acetamido]cephalosporin derivatives | |
| EP0098615B1 (en) | 1-oxadethiacephalosporin compound and antibacterial agent containing the same | |
| US3879384A (en) | 7-{8 2-(1-and 2 cyclopenten-1-yl)acetamido{9 cephalosporanic acids | |
| CA1089445A (en) | 3-cephem derivatives | |
| DK143603B (da) | Analogifremgangsmaade til fremstilling af aminoalkylestere af penicilliner | |
| PL196039B1 (pl) | Sposób wytwarzania związku 3-hydroksymetylocefemowego |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired |
Owner name: GLAXO GROUP LIMITED |